Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

Presentation

Field Cancerization Therapies: Medical Dermatology and Beyond

Description

The presentation discusses various therapies for field cancerization, particularly concerning non-melanoma skin cancer and the treatment of actinic keratosis. Given the complexities involved, factors influencing treatment choices include patient demographics (age, social circumstances), lesion characteristics (number, size, and location), and treatment specifics (duration and side effects). Several treatment modalities are explored, from cryotherapy and lasers to photodynamic therapy (PDT) and new drug applications. The concept of wound healing is highlighted, with discussions on the effectiveness of different needle lengths for micro-needling and the timing of drug application relative to laser treatment. Several researchers are acknowledged for their contributions to the field, and the presentation emphasizes the clinical experience of treating patients, noting the importance of personalized care and shared decision-making. Innovations such as daylight PDT and the potential of HPV vaccination for prevention are also addressed, citing ongoing studies. Ultimately, the need for innovative, patience-centered therapeutic approaches is underscored, particularly as actinic keratosis requires ongoing management due to its chronic nature.

View more

Conclusions

Patient-related factors, lesion-related factors, and treatment-related factors significantly influence treatment decisions for actinic keratosis.
Field-directed treatments are effective for larger areas with multiple actinic keratosis lesions.
Photodynamic therapy (PDT) shows promise in treating actinic keratosis with an emphasis on patient comfort during treatment.
Daylight PDT is comparable in effectiveness to conventional PDT and offers better patient tolerance and convenience.
Self-administration of treatments enhances patient engagement and adherence, particularly for those in real-life conditions.
Ablative laser treatments combined with PDT can provide synergistic benefits in reducing actinic keratosis lesions.
Vaccination strategies using HPV vaccines may significantly reduce the burden of actinic keratosis and related skin cancers.
Individualized treatment plans and shared decision-making between physician and patient are crucial, especially for elderly patients.
Continued research and clinical trials are necessary for the development of new drugs and combination therapies to improve outcomes for patients with actinic keratosis.

Heppt M et al. (2022) Treatment of actinic keratoses, infoportal-hautkrebs.de
Frommeyer TC, Rohan CA, Spandau DF et al. (2022) Front Oncol 11:813132
Spandau DF, Chen R, Wargo J et al. (2021) J Clin Invest 131:e150972
Trovato E et al. (2023) Lasers Surg Med 55:642-652
Klein A et al., BJD 2015
Wiegell S et al., Br J Dermatol 2008; 158: 740-6
Okhovat JP, Shumaker P, Lee KC (2022) J Am Acad Dermatol 1444-1446
García-Gil MF et al. (2022) Dermatol Ther 35:e15879; doi.org/10.1111/dth.15897
Falkenberg C et al. (2021) Photodiagnos Photodyn 34:102249
Nashan D, Hüning S, Heppt MV, Brehmer A, Berking C (2020) Hautarzt 71:463-475
Torezan L, Grinblat B, Haedersdal M et al. (2021) Eur J Dermatol 31:638-644
Garcia-Cazaña T et al. (2019) Photodiagnosis Photodyn Ther 27:34-8
Neagu N, Dianzani C, Venuti A, Bonin S, Voidazan S, Zalaudek I, Conforti C (2023) JEADV 37:40-46
Wenande E, Bech-Thomsen N, Togsverd-Bo K, Haedersdal M (2021) Case Rep Dermatol 13:457-463
Cramer P, Stockfleth E (2020) Actinic keratosis: where do we stand and where is the future going to take us? Expert Opin Emerg Drugs 25:49-58
Härter M (2007) Patientenbeteiligung bei medizinischen Entscheidungen. Effekte der Partizipativen Entscheidungsfindung aus systematischen Reviews. Dtsch Ärztebl 104, A-1483